Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 110 participants.
Also called NCT02275260
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 110 participants
- Registry
-
NCT02275260
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Czechia, Germany, Hungary, Netherlands, Switzerland
- Registry status
- Terminated
Technical summary
Registry record NCT02275260. Allocation not applicable; no masking; primary purpose screening. Start 2014-12 (actual); primary completion 2017-02-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- Cerebral Diffusion-Weighted Magnetic Resonance Imaging
- Intervention (Device)
- Transesophageal Echocardiography
- Intervention (Other)
- Paperbased neurocognitive testing
- Lead sponsor
- Biotronik SE & Co. KG
- Collaborator
- University Hospital Heidelberg
Record details
- Record id
cardio:ct-nct02275260- Content hash
864c03a3316ee5c650b0104b82a3a8fc949a501f4ae8b4741587637d75c2e61d